The 2024 PSCI China Supplier Conference, held in Nanjing on September 10-11, was a significant milestone in our efforts to promote sustainability within the pharmaceutical supply chain. With 276 attendees from 136 supplier sites across both days, the strong participation underscores the importance of responsible supply chains in our industry.

This year’s conference featured a deeper focus on critical topics such as climate change and social responsibility. Companies like Roche shared their concrete plans for decarbonising their supply chain and engaging suppliers. On the social responsibility front, AstraZeneca provided insights into helping suppliers meet PSCI's expectations for responsible labor practices, tailored to the local context in China.

The quality of discussions and presentations continues to improve year after year. This event provided valuable opportunities for learning, with attendees engaging actively in discussions and follow-up networking sessions.

We owe the success of this event to the hard work and dedication of our China sub-team, who played a key role in shaping the agenda. We also extend our gratitude to the Capability Committee and Topic teams for their efforts in ensuring that the content was both informative and impactful.

Many thanks to all members of our China team in particular the co-Leads who contributed greatly in developing the agenda and securing expert speakers; Wenjia XU, and Li Liu; and those who contributed their knowledge as speakers Gary Lu, Suijing Zhou, Wenjun Wang and Joyce Jiang.

Other companies that contributed to the event organisation and/or spoke at the event included: GSK, Novartis, Jiuzhou Pharma, DEKRA, ERM , Shanghai STRM Technology, Business for Social Responsibility, Peterson Solutions China, BSI.

As we reflect on the success of this conference, we are energized to continue our work in fostering a more sustainable pharmaceutical supply chain. We look forward to your ongoing support and participation in our future initiatives.